STAAR Surgical Company STAA
NASDAQ
| 10/02/2026 | 07/03/2026 | 04/03/2026 | 01/02/2026 | 09/26/2025 | |
|---|---|---|---|---|---|
| Net Income | -30.81% | 54.78% | 128.43% | -306.09% | 152.84% |
| Total Depreciation and Amortization | 1.84% | 13.43% | 4.98% | 0.35% | 1.27% |
| Total Amortization of Deferred Charges | -0.11% | 812.50% | -74.57% | 293.27% | -29.25% |
| Total Other Non-Cash Items | -74.19% | -19.14% | 22.80% | -51.02% | 829.95% |
| Change in Net Operating Assets | 678.43% | 93.71% | -4,719.91% | 102.99% | -106.13% |
| Cash from Operations | 38.73% | 190.76% | -454.29% | -246.76% | 109.79% |
| Capital Expenditure | -89.27% | -11.51% | 73.58% | -89.92% | 50.73% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -4,456.54% | -133.67% | 114.60% | -387.67% | -77.09% |
| Cash from Investing | -2,877.16% | -163.62% | 111.06% | -467.50% | -78.97% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.68% | 612.07% | 52.63% | -96.16% | 24,608.33% |
| Repurchase of Common Stock | 51.73% | -46.81% | -1,038.41% | 91.73% | 56.46% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 12.18% | 11.28% | -3,286.00% | -105.09% | 121.65% |
| Foreign Exchange rate Adjustments | -177.57% | -137.78% | -112.03% | 310.99% | -86.73% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -189.55% | 178.53% | 7.47% | -354.93% | 250.83% |